Pharmwar

FDA HAS APPROVED SUNLENCA (LENACAPAVIR), A NEW ANTIRETROVIRAL DRUG FOR THE TREATMENT OF HIV-1 IN ADULT PATIENTS WHO HAVE NOT RESPONDED TO OTHER TREATMENTS

SCIENTIFIC CONSENSUS IS THAT THERE IS NO CONSISTENT OR RELIABLE EVIDENCE THAT RANITIDINE INCREASES THE RISK OF ANY CANCER

How many pharmacists per country

EMA RECOMMENDS THE WITHDRAWAL OF MEDICINES CONTAINING ANTITUSSIVE PHOLCODINE

FDA approves Rebyota, a first-in-class medication for the prevention of recurrent clostridium difficile infections